WET AGE-RELATED MACULAR DEGENERATION (AMD)

Clinical trials for WET AGE-RELATED MACULAR DEGENERATION (AMD) explained in plain language.

Never miss a new study

Get alerted when new WET AGE-RELATED MACULAR DEGENERATION (AMD) trials appear

Sign up with your email to follow new studies for WET AGE-RELATED MACULAR DEGENERATION (AMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Pill for blinding eye disease enters human testing

Disease control Recruiting now

This study is testing a new oral tablet called HX9428 for people with wet age-related macular degeneration, a leading cause of vision loss. The first part checks the safety and correct dose of the pill. The second part will look for early signs that the pill can help improve or s…

Matched conditions: WET AGE-RELATED MACULAR DEGENERATION (AMD)

Phase: PHASE1, PHASE2 • Sponsor: Fujian Haixi Pharmaceuticals Co., Ltd. • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

WET AGE-RELATED MACULAR DEGENERATION (AMD)

Get alerted when new WET AGE-RELATED MACULAR DEGENERATION (AMD) trials appear

Pill for blinding eye disease enters human testing